Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
17 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/five-year-pharmacovigilance-study-by-ntc-confirms-safety-of-fixed-dose-eye-drops-for-post-cataract-surgery-302502272.html
07 Dec 2024
// INDPHARMAPOST
https://www.indianpharmapost.com/news/ntc-presents-positive-results-from-phase-ii-mirakle-study-evaluating-an-innovative-drug-for-bacterial-conjunctivitis-16510
05 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ntc-presents-positive-results-from-phase-ii-mirakle-study-evaluating-an-innovative-drug-for-bacterial-conjunctivitis-302321325.html
07 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ntc-launches-imperial-the-new-eye-drops-product-line-on-the-patients-side-302263058.html
30 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ntc-gives-long-term-consistency-to-its-ophtha-portfolio-with-another-mdr-ce-certificate-approval-302154587.html
24 Nov 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/ntc-und-aspen-geben-positives-sahpra-ergebnis-fur-die-fest-dosierte-kombination-aus-levofloxacin-und-dexamethason-augentropfen-in-mehreren-dosen-bekannt-809733682.html
ABOUT THIS PAGE